Andexanet-Alfa-Associated Heparin Resistance in the Context of Hemorrhagic Stroke

BACKGROUND: With a growing number of patients on new oral anticoagulants, interest in reversal agents is rising. Andexanet alfa is used for reversal of factor Xa inhibitors in intracranial hemorrhage. METHODS: We provide a brief review on andexanet-alfa-associated heparin resistance and discuss pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Müther, Michael, Schwindt, Wolfram, Mesters, Rolf Michael, Minnerup, Jens, Stracke, Paul, Holling, Markus, Wiendl, Heinz, Stummer, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519708/
https://www.ncbi.nlm.nih.gov/pubmed/35931915
http://dx.doi.org/10.1007/s12028-022-01573-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519708/
https://www.ncbi.nlm.nih.gov/pubmed/35931915
http://dx.doi.org/10.1007/s12028-022-01573-5

Ejemplares similares